nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—pancreatic cancer	0.634	1	CbGaD
Magnesium salicylate—ALB—Erlotinib—pancreatic cancer	0.082	0.361	CbGbCtD
Magnesium salicylate—ALB—Irinotecan—pancreatic cancer	0.0741	0.326	CbGbCtD
Magnesium salicylate—ALB—Fluorouracil—pancreatic cancer	0.0711	0.313	CbGbCtD
Magnesium salicylate—Trisalicylate-choline—PTGS2—pancreatic cancer	0.00151	0.21	CrCbGaD
Magnesium salicylate—Olsalazine—PPARG—pancreatic cancer	0.00148	0.207	CrCbGaD
Magnesium salicylate—Burning sensation—Docetaxel—pancreatic cancer	0.00126	0.00962	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Gemcitabine—pancreatic cancer	0.00117	0.00899	CcSEcCtD
Magnesium salicylate—Oesophagitis—Fluorouracil—pancreatic cancer	0.00111	0.00846	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.00108	0.00824	CcSEcCtD
Magnesium salicylate—Hypothermia—Epirubicin—pancreatic cancer	0.00105	0.00804	CcSEcCtD
Magnesium salicylate—Body temperature decreased—Epirubicin—pancreatic cancer	0.00105	0.00804	CcSEcCtD
Magnesium salicylate—Weight increased—Tamoxifen—pancreatic cancer	0.00102	0.00782	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Sunitinib—pancreatic cancer	0.00102	0.00778	CcSEcCtD
Magnesium salicylate—Gastric ulcer—Epirubicin—pancreatic cancer	0.00101	0.00776	CcSEcCtD
Magnesium salicylate—Deafness—Gemcitabine—pancreatic cancer	0.000998	0.00764	CcSEcCtD
Magnesium salicylate—Body temperature decreased—Doxorubicin—pancreatic cancer	0.000972	0.00744	CcSEcCtD
Magnesium salicylate—Hypothermia—Doxorubicin—pancreatic cancer	0.000972	0.00744	CcSEcCtD
Magnesium salicylate—Sweating—Tamoxifen—pancreatic cancer	0.00096	0.00735	CcSEcCtD
Magnesium salicylate—Gastric ulcer—Doxorubicin—pancreatic cancer	0.000937	0.00718	CcSEcCtD
Magnesium salicylate—Epistaxis—Erlotinib—pancreatic cancer	0.000934	0.00715	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Sunitinib—pancreatic cancer	0.000922	0.00706	CcSEcCtD
Magnesium salicylate—Hearing impaired—Docetaxel—pancreatic cancer	0.000917	0.00702	CcSEcCtD
Magnesium salicylate—Salicylate-sodium—PTGS2—pancreatic cancer	0.000913	0.127	CrCbGaD
Magnesium salicylate—Hepatitis—Tamoxifen—pancreatic cancer	0.000899	0.00688	CcSEcCtD
Magnesium salicylate—Lethargy—Fluorouracil—pancreatic cancer	0.000896	0.00686	CcSEcCtD
Magnesium salicylate—Hepatitis—Erlotinib—pancreatic cancer	0.000889	0.00681	CcSEcCtD
Magnesium salicylate—Ketoprofen—CXCL8—pancreatic cancer	0.000889	0.124	CrCbGaD
Magnesium salicylate—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00085	0.00651	CcSEcCtD
Magnesium salicylate—Burning sensation—Epirubicin—pancreatic cancer	0.000848	0.00649	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Erlotinib—pancreatic cancer	0.000841	0.00644	CcSEcCtD
Magnesium salicylate—Flushing—Tamoxifen—pancreatic cancer	0.000834	0.00639	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Docetaxel—pancreatic cancer	0.000833	0.00638	CcSEcCtD
Magnesium salicylate—Epistaxis—Sunitinib—pancreatic cancer	0.000809	0.00619	CcSEcCtD
Magnesium salicylate—Oesophagitis—Docetaxel—pancreatic cancer	0.000798	0.00611	CcSEcCtD
Magnesium salicylate—Burning sensation—Doxorubicin—pancreatic cancer	0.000784	0.006	CcSEcCtD
Magnesium salicylate—Erythema—Tamoxifen—pancreatic cancer	0.000783	0.00599	CcSEcCtD
Magnesium salicylate—Lightheadedness—Docetaxel—pancreatic cancer	0.000781	0.00598	CcSEcCtD
Magnesium salicylate—Erythema—Erlotinib—pancreatic cancer	0.000774	0.00593	CcSEcCtD
Magnesium salicylate—Hepatitis—Sunitinib—pancreatic cancer	0.00077	0.00589	CcSEcCtD
Magnesium salicylate—Dysgeusia—Tamoxifen—pancreatic cancer	0.000766	0.00587	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Sunitinib—pancreatic cancer	0.000728	0.00557	CcSEcCtD
Magnesium salicylate—Stinging—Epirubicin—pancreatic cancer	0.000727	0.00556	CcSEcCtD
Magnesium salicylate—Flushing—Sunitinib—pancreatic cancer	0.000715	0.00547	CcSEcCtD
Magnesium salicylate—Deafness—Docetaxel—pancreatic cancer	0.000708	0.00542	CcSEcCtD
Magnesium salicylate—Sweating—Irinotecan—pancreatic cancer	0.000677	0.00518	CcSEcCtD
Magnesium salicylate—Stinging—Doxorubicin—pancreatic cancer	0.000673	0.00515	CcSEcCtD
Magnesium salicylate—Erythema—Sunitinib—pancreatic cancer	0.00067	0.00513	CcSEcCtD
Magnesium salicylate—Sweating—Gemcitabine—pancreatic cancer	0.00066	0.00505	CcSEcCtD
Magnesium salicylate—Dysgeusia—Sunitinib—pancreatic cancer	0.000656	0.00502	CcSEcCtD
Magnesium salicylate—Lethargy—Docetaxel—pancreatic cancer	0.000647	0.00495	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Epirubicin—pancreatic cancer	0.000643	0.00492	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—pancreatic cancer	0.00064	0.0892	CrCbGaD
Magnesium salicylate—Oedema—Tamoxifen—pancreatic cancer	0.000639	0.00489	CcSEcCtD
Magnesium salicylate—Epistaxis—Fluorouracil—pancreatic cancer	0.000638	0.00489	CcSEcCtD
Magnesium salicylate—Oedema—Erlotinib—pancreatic cancer	0.000632	0.00484	CcSEcCtD
Magnesium salicylate—Olsalazine—PTGS2—pancreatic cancer	0.000626	0.0872	CrCbGaD
Magnesium salicylate—Shock—Erlotinib—pancreatic cancer	0.000622	0.00476	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000617	0.00473	CcSEcCtD
Magnesium salicylate—Anorexia—Tamoxifen—pancreatic cancer	0.000609	0.00466	CcSEcCtD
Magnesium salicylate—Anorexia—Erlotinib—pancreatic cancer	0.000602	0.00461	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Doxorubicin—pancreatic cancer	0.000595	0.00456	CcSEcCtD
Magnesium salicylate—Flushing—Irinotecan—pancreatic cancer	0.000589	0.00451	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000584	0.00447	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Docetaxel—pancreatic cancer	0.000579	0.00443	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Epirubicin—pancreatic cancer	0.000562	0.0043	CcSEcCtD
Magnesium salicylate—Dyspepsia—Tamoxifen—pancreatic cancer	0.000562	0.0043	CcSEcCtD
Magnesium salicylate—Dyspepsia—Erlotinib—pancreatic cancer	0.000556	0.00426	CcSEcCtD
Magnesium salicylate—Decreased appetite—Tamoxifen—pancreatic cancer	0.000555	0.00425	CcSEcCtD
Magnesium salicylate—Decreased appetite—Erlotinib—pancreatic cancer	0.000549	0.0042	CcSEcCtD
Magnesium salicylate—Oedema—Sunitinib—pancreatic cancer	0.000547	0.00419	CcSEcCtD
Magnesium salicylate—Constipation—Tamoxifen—pancreatic cancer	0.000546	0.00418	CcSEcCtD
Magnesium salicylate—Pain—Tamoxifen—pancreatic cancer	0.000546	0.00418	CcSEcCtD
Magnesium salicylate—Pain—Erlotinib—pancreatic cancer	0.00054	0.00414	CcSEcCtD
Magnesium salicylate—Constipation—Erlotinib—pancreatic cancer	0.00054	0.00414	CcSEcCtD
Magnesium salicylate—Shock—Sunitinib—pancreatic cancer	0.000538	0.00412	CcSEcCtD
Magnesium salicylate—Oesophagitis—Epirubicin—pancreatic cancer	0.000538	0.00412	CcSEcCtD
Magnesium salicylate—Erythema—Gemcitabine—pancreatic cancer	0.000538	0.00412	CcSEcCtD
Magnesium salicylate—Ecchymosis—Epirubicin—pancreatic cancer	0.000532	0.00408	CcSEcCtD
Magnesium salicylate—Salsalate—PTGS2—pancreatic cancer	0.000532	0.0741	CrCbGaD
Magnesium salicylate—Erythema—Fluorouracil—pancreatic cancer	0.000529	0.00405	CcSEcCtD
Magnesium salicylate—Anorexia—Sunitinib—pancreatic cancer	0.000521	0.00399	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Doxorubicin—pancreatic cancer	0.00052	0.00398	CcSEcCtD
Magnesium salicylate—Urticaria—Tamoxifen—pancreatic cancer	0.000507	0.00388	CcSEcCtD
Magnesium salicylate—Weight increased—Docetaxel—pancreatic cancer	0.000498	0.00382	CcSEcCtD
Magnesium salicylate—Oesophagitis—Doxorubicin—pancreatic cancer	0.000498	0.00381	CcSEcCtD
Magnesium salicylate—Ecchymosis—Doxorubicin—pancreatic cancer	0.000493	0.00377	CcSEcCtD
Magnesium salicylate—Dyspepsia—Sunitinib—pancreatic cancer	0.000481	0.00369	CcSEcCtD
Magnesium salicylate—Decreased appetite—Sunitinib—pancreatic cancer	0.000475	0.00364	CcSEcCtD
Magnesium salicylate—Pain—Sunitinib—pancreatic cancer	0.000468	0.00358	CcSEcCtD
Magnesium salicylate—Constipation—Sunitinib—pancreatic cancer	0.000468	0.00358	CcSEcCtD
Magnesium salicylate—Epistaxis—Docetaxel—pancreatic cancer	0.000461	0.00353	CcSEcCtD
Magnesium salicylate—Confusional state—Irinotecan—pancreatic cancer	0.000454	0.00348	CcSEcCtD
Magnesium salicylate—Pruritus—Tamoxifen—pancreatic cancer	0.000452	0.00346	CcSEcCtD
Magnesium salicylate—Oedema—Irinotecan—pancreatic cancer	0.000451	0.00345	CcSEcCtD
Magnesium salicylate—Pruritus—Erlotinib—pancreatic cancer	0.000447	0.00342	CcSEcCtD
Magnesium salicylate—Shock—Irinotecan—pancreatic cancer	0.000443	0.00339	CcSEcCtD
Magnesium salicylate—Oedema—Gemcitabine—pancreatic cancer	0.000439	0.00336	CcSEcCtD
Magnesium salicylate—Hepatitis—Docetaxel—pancreatic cancer	0.000438	0.00336	CcSEcCtD
Magnesium salicylate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000437	0.00334	CcSEcCtD
Magnesium salicylate—Lethargy—Epirubicin—pancreatic cancer	0.000436	0.00334	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000436	0.00333	CcSEcCtD
Magnesium salicylate—Confusional state—Fluorouracil—pancreatic cancer	0.000435	0.00333	CcSEcCtD
Magnesium salicylate—Diarrhoea—Erlotinib—pancreatic cancer	0.000432	0.00331	CcSEcCtD
Magnesium salicylate—Oedema—Fluorouracil—pancreatic cancer	0.000432	0.0033	CcSEcCtD
Magnesium salicylate—Anorexia—Irinotecan—pancreatic cancer	0.000429	0.00329	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000424	0.00325	CcSEcCtD
Magnesium salicylate—Dizziness—Tamoxifen—pancreatic cancer	0.000422	0.00323	CcSEcCtD
Magnesium salicylate—Hypotension—Irinotecan—pancreatic cancer	0.000421	0.00322	CcSEcCtD
Magnesium salicylate—Anorexia—Gemcitabine—pancreatic cancer	0.000418	0.0032	CcSEcCtD
Magnesium salicylate—Dizziness—Erlotinib—pancreatic cancer	0.000418	0.0032	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Docetaxel—pancreatic cancer	0.000415	0.00317	CcSEcCtD
Magnesium salicylate—Anorexia—Fluorouracil—pancreatic cancer	0.000411	0.00315	CcSEcCtD
Magnesium salicylate—Hypotension—Gemcitabine—pancreatic cancer	0.00041	0.00314	CcSEcCtD
Magnesium salicylate—Flushing—Docetaxel—pancreatic cancer	0.000407	0.00311	CcSEcCtD
Magnesium salicylate—Vomiting—Tamoxifen—pancreatic cancer	0.000406	0.00311	CcSEcCtD
Magnesium salicylate—Lethargy—Doxorubicin—pancreatic cancer	0.000404	0.00309	CcSEcCtD
Magnesium salicylate—Hypotension—Fluorouracil—pancreatic cancer	0.000403	0.00309	CcSEcCtD
Magnesium salicylate—Rash—Tamoxifen—pancreatic cancer	0.000403	0.00308	CcSEcCtD
Magnesium salicylate—Dermatitis—Tamoxifen—pancreatic cancer	0.000402	0.00308	CcSEcCtD
Magnesium salicylate—Vomiting—Erlotinib—pancreatic cancer	0.000402	0.00308	CcSEcCtD
Magnesium salicylate—Somnolence—Irinotecan—pancreatic cancer	0.000401	0.00307	CcSEcCtD
Magnesium salicylate—Headache—Tamoxifen—pancreatic cancer	0.0004	0.00306	CcSEcCtD
Magnesium salicylate—Rash—Erlotinib—pancreatic cancer	0.000398	0.00305	CcSEcCtD
Magnesium salicylate—Dermatitis—Erlotinib—pancreatic cancer	0.000398	0.00305	CcSEcCtD
Magnesium salicylate—Dyspepsia—Irinotecan—pancreatic cancer	0.000397	0.00304	CcSEcCtD
Magnesium salicylate—Headache—Erlotinib—pancreatic cancer	0.000396	0.00303	CcSEcCtD
Magnesium salicylate—Decreased appetite—Irinotecan—pancreatic cancer	0.000392	0.003	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Epirubicin—pancreatic cancer	0.00039	0.00299	CcSEcCtD
Magnesium salicylate—Somnolence—Gemcitabine—pancreatic cancer	0.00039	0.00299	CcSEcCtD
Magnesium salicylate—Pruritus—Sunitinib—pancreatic cancer	0.000387	0.00296	CcSEcCtD
Magnesium salicylate—Pain—Irinotecan—pancreatic cancer	0.000385	0.00295	CcSEcCtD
Magnesium salicylate—Constipation—Irinotecan—pancreatic cancer	0.000385	0.00295	CcSEcCtD
Magnesium salicylate—Somnolence—Fluorouracil—pancreatic cancer	0.000384	0.00294	CcSEcCtD
Magnesium salicylate—Erythema—Docetaxel—pancreatic cancer	0.000382	0.00292	CcSEcCtD
Magnesium salicylate—Decreased appetite—Gemcitabine—pancreatic cancer	0.000382	0.00292	CcSEcCtD
Magnesium salicylate—Dyspepsia—Fluorouracil—pancreatic cancer	0.00038	0.00291	CcSEcCtD
Magnesium salicylate—Nausea—Tamoxifen—pancreatic cancer	0.000379	0.0029	CcSEcCtD
Magnesium salicylate—Constipation—Gemcitabine—pancreatic cancer	0.000375	0.00287	CcSEcCtD
Magnesium salicylate—Pain—Gemcitabine—pancreatic cancer	0.000375	0.00287	CcSEcCtD
Magnesium salicylate—Nausea—Erlotinib—pancreatic cancer	0.000375	0.00287	CcSEcCtD
Magnesium salicylate—Decreased appetite—Fluorouracil—pancreatic cancer	0.000375	0.00287	CcSEcCtD
Magnesium salicylate—Diarrhoea—Sunitinib—pancreatic cancer	0.000374	0.00286	CcSEcCtD
Magnesium salicylate—Dysgeusia—Docetaxel—pancreatic cancer	0.000374	0.00286	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000371	0.00284	CcSEcCtD
Magnesium salicylate—Asthma—Epirubicin—pancreatic cancer	0.000369	0.00283	CcSEcCtD
Magnesium salicylate—Pain—Fluorouracil—pancreatic cancer	0.000369	0.00282	CcSEcCtD
Magnesium salicylate—Dizziness—Sunitinib—pancreatic cancer	0.000362	0.00277	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000362	0.00277	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000361	0.00276	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000356	0.00272	CcSEcCtD
Magnesium salicylate—Vomiting—Sunitinib—pancreatic cancer	0.000348	0.00266	CcSEcCtD
Magnesium salicylate—Rash—Sunitinib—pancreatic cancer	0.000345	0.00264	CcSEcCtD
Magnesium salicylate—Dermatitis—Sunitinib—pancreatic cancer	0.000345	0.00264	CcSEcCtD
Magnesium salicylate—Urticaria—Fluorouracil—pancreatic cancer	0.000343	0.00262	CcSEcCtD
Magnesium salicylate—Headache—Sunitinib—pancreatic cancer	0.000343	0.00262	CcSEcCtD
Magnesium salicylate—Asthma—Doxorubicin—pancreatic cancer	0.000342	0.00262	CcSEcCtD
Magnesium salicylate—Weight increased—Epirubicin—pancreatic cancer	0.000336	0.00257	CcSEcCtD
Magnesium salicylate—Drowsiness—Epirubicin—pancreatic cancer	0.000329	0.00252	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—pancreatic cancer	0.000327	0.0456	CrCbGaD
Magnesium salicylate—Nausea—Sunitinib—pancreatic cancer	0.000325	0.00249	CcSEcCtD
Magnesium salicylate—Sweating—Epirubicin—pancreatic cancer	0.000316	0.00242	CcSEcCtD
Magnesium salicylate—Confusional state—Docetaxel—pancreatic cancer	0.000314	0.0024	CcSEcCtD
Magnesium salicylate—Oedema—Docetaxel—pancreatic cancer	0.000311	0.00238	CcSEcCtD
Magnesium salicylate—Weight increased—Doxorubicin—pancreatic cancer	0.000311	0.00238	CcSEcCtD
Magnesium salicylate—Epistaxis—Epirubicin—pancreatic cancer	0.000311	0.00238	CcSEcCtD
Magnesium salicylate—Pruritus—Gemcitabine—pancreatic cancer	0.000311	0.00238	CcSEcCtD
Magnesium salicylate—Diarrhoea—Irinotecan—pancreatic cancer	0.000308	0.00236	CcSEcCtD
Magnesium salicylate—Shock—Docetaxel—pancreatic cancer	0.000306	0.00235	CcSEcCtD
Magnesium salicylate—Pruritus—Fluorouracil—pancreatic cancer	0.000305	0.00234	CcSEcCtD
Magnesium salicylate—Drowsiness—Doxorubicin—pancreatic cancer	0.000305	0.00233	CcSEcCtD
Magnesium salicylate—Diarrhoea—Gemcitabine—pancreatic cancer	0.0003	0.0023	CcSEcCtD
Magnesium salicylate—Dizziness—Irinotecan—pancreatic cancer	0.000298	0.00228	CcSEcCtD
Magnesium salicylate—Anorexia—Docetaxel—pancreatic cancer	0.000297	0.00227	CcSEcCtD
Magnesium salicylate—Hepatitis—Epirubicin—pancreatic cancer	0.000296	0.00226	CcSEcCtD
Magnesium salicylate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000295	0.00226	CcSEcCtD
Magnesium salicylate—Sweating—Doxorubicin—pancreatic cancer	0.000292	0.00224	CcSEcCtD
Magnesium salicylate—Hypotension—Docetaxel—pancreatic cancer	0.000291	0.00223	CcSEcCtD
Magnesium salicylate—Epistaxis—Doxorubicin—pancreatic cancer	0.000287	0.0022	CcSEcCtD
Magnesium salicylate—Vomiting—Irinotecan—pancreatic cancer	0.000286	0.00219	CcSEcCtD
Magnesium salicylate—Dizziness—Fluorouracil—pancreatic cancer	0.000285	0.00218	CcSEcCtD
Magnesium salicylate—Rash—Irinotecan—pancreatic cancer	0.000284	0.00217	CcSEcCtD
Magnesium salicylate—Dermatitis—Irinotecan—pancreatic cancer	0.000284	0.00217	CcSEcCtD
Magnesium salicylate—Headache—Irinotecan—pancreatic cancer	0.000282	0.00216	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Epirubicin—pancreatic cancer	0.00028	0.00214	CcSEcCtD
Magnesium salicylate—Vomiting—Gemcitabine—pancreatic cancer	0.000279	0.00214	CcSEcCtD
Magnesium salicylate—Somnolence—Docetaxel—pancreatic cancer	0.000277	0.00212	CcSEcCtD
Magnesium salicylate—Rash—Gemcitabine—pancreatic cancer	0.000277	0.00212	CcSEcCtD
Magnesium salicylate—Dermatitis—Gemcitabine—pancreatic cancer	0.000276	0.00212	CcSEcCtD
Magnesium salicylate—Tinnitus—Epirubicin—pancreatic cancer	0.000276	0.00211	CcSEcCtD
Magnesium salicylate—Headache—Gemcitabine—pancreatic cancer	0.000275	0.0021	CcSEcCtD
Magnesium salicylate—Flushing—Epirubicin—pancreatic cancer	0.000274	0.0021	CcSEcCtD
Magnesium salicylate—Vomiting—Fluorouracil—pancreatic cancer	0.000274	0.0021	CcSEcCtD
Magnesium salicylate—Dyspepsia—Docetaxel—pancreatic cancer	0.000274	0.0021	CcSEcCtD
Magnesium salicylate—Hepatitis—Doxorubicin—pancreatic cancer	0.000274	0.00209	CcSEcCtD
Magnesium salicylate—Rash—Fluorouracil—pancreatic cancer	0.000272	0.00208	CcSEcCtD
Magnesium salicylate—Dermatitis—Fluorouracil—pancreatic cancer	0.000272	0.00208	CcSEcCtD
Magnesium salicylate—Decreased appetite—Docetaxel—pancreatic cancer	0.000271	0.00207	CcSEcCtD
Magnesium salicylate—Headache—Fluorouracil—pancreatic cancer	0.00027	0.00207	CcSEcCtD
Magnesium salicylate—Nausea—Irinotecan—pancreatic cancer	0.000268	0.00205	CcSEcCtD
Magnesium salicylate—Pain—Docetaxel—pancreatic cancer	0.000266	0.00204	CcSEcCtD
Magnesium salicylate—Constipation—Docetaxel—pancreatic cancer	0.000266	0.00204	CcSEcCtD
Magnesium salicylate—Nausea—Gemcitabine—pancreatic cancer	0.000261	0.002	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS2—pancreatic cancer	0.000259	0.0362	CrCbGaD
Magnesium salicylate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000259	0.00198	CcSEcCtD
Magnesium salicylate—Erythema—Epirubicin—pancreatic cancer	0.000257	0.00197	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000257	0.00196	CcSEcCtD
Magnesium salicylate—Nausea—Fluorouracil—pancreatic cancer	0.000256	0.00196	CcSEcCtD
Magnesium salicylate—Tinnitus—Doxorubicin—pancreatic cancer	0.000255	0.00195	CcSEcCtD
Magnesium salicylate—Flushing—Doxorubicin—pancreatic cancer	0.000254	0.00194	CcSEcCtD
Magnesium salicylate—Dysgeusia—Epirubicin—pancreatic cancer	0.000252	0.00193	CcSEcCtD
Magnesium salicylate—Erythema—Doxorubicin—pancreatic cancer	0.000238	0.00182	CcSEcCtD
Magnesium salicylate—Dysgeusia—Doxorubicin—pancreatic cancer	0.000233	0.00179	CcSEcCtD
Magnesium salicylate—Pruritus—Docetaxel—pancreatic cancer	0.00022	0.00169	CcSEcCtD
Magnesium salicylate—Diarrhoea—Docetaxel—pancreatic cancer	0.000213	0.00163	CcSEcCtD
Magnesium salicylate—Confusional state—Epirubicin—pancreatic cancer	0.000212	0.00162	CcSEcCtD
Magnesium salicylate—Oedema—Epirubicin—pancreatic cancer	0.00021	0.00161	CcSEcCtD
Magnesium salicylate—Shock—Epirubicin—pancreatic cancer	0.000207	0.00158	CcSEcCtD
Magnesium salicylate—Dizziness—Docetaxel—pancreatic cancer	0.000206	0.00158	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000203	0.00155	CcSEcCtD
Magnesium salicylate—Anorexia—Epirubicin—pancreatic cancer	0.0002	0.00153	CcSEcCtD
Magnesium salicylate—Vomiting—Docetaxel—pancreatic cancer	0.000198	0.00152	CcSEcCtD
Magnesium salicylate—Rash—Docetaxel—pancreatic cancer	0.000196	0.0015	CcSEcCtD
Magnesium salicylate—Hypotension—Epirubicin—pancreatic cancer	0.000196	0.0015	CcSEcCtD
Magnesium salicylate—Dermatitis—Docetaxel—pancreatic cancer	0.000196	0.0015	CcSEcCtD
Magnesium salicylate—Confusional state—Doxorubicin—pancreatic cancer	0.000196	0.0015	CcSEcCtD
Magnesium salicylate—Headache—Docetaxel—pancreatic cancer	0.000195	0.00149	CcSEcCtD
Magnesium salicylate—Oedema—Doxorubicin—pancreatic cancer	0.000194	0.00149	CcSEcCtD
Magnesium salicylate—Shock—Doxorubicin—pancreatic cancer	0.000191	0.00146	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000188	0.00144	CcSEcCtD
Magnesium salicylate—Somnolence—Epirubicin—pancreatic cancer	0.000187	0.00143	CcSEcCtD
Magnesium salicylate—Anorexia—Doxorubicin—pancreatic cancer	0.000185	0.00142	CcSEcCtD
Magnesium salicylate—Nausea—Docetaxel—pancreatic cancer	0.000185	0.00142	CcSEcCtD
Magnesium salicylate—Dyspepsia—Epirubicin—pancreatic cancer	0.000185	0.00142	CcSEcCtD
Magnesium salicylate—Decreased appetite—Epirubicin—pancreatic cancer	0.000183	0.0014	CcSEcCtD
Magnesium salicylate—Hypotension—Doxorubicin—pancreatic cancer	0.000182	0.00139	CcSEcCtD
Magnesium salicylate—Pain—Epirubicin—pancreatic cancer	0.00018	0.00138	CcSEcCtD
Magnesium salicylate—Constipation—Epirubicin—pancreatic cancer	0.00018	0.00138	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000173	0.00133	CcSEcCtD
Magnesium salicylate—Somnolence—Doxorubicin—pancreatic cancer	0.000173	0.00132	CcSEcCtD
Magnesium salicylate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000171	0.00131	CcSEcCtD
Magnesium salicylate—Decreased appetite—Doxorubicin—pancreatic cancer	0.000169	0.00129	CcSEcCtD
Magnesium salicylate—Urticaria—Epirubicin—pancreatic cancer	0.000167	0.00128	CcSEcCtD
Magnesium salicylate—Pain—Doxorubicin—pancreatic cancer	0.000166	0.00127	CcSEcCtD
Magnesium salicylate—Constipation—Doxorubicin—pancreatic cancer	0.000166	0.00127	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00016	0.00123	CcSEcCtD
Magnesium salicylate—Urticaria—Doxorubicin—pancreatic cancer	0.000154	0.00118	CcSEcCtD
Magnesium salicylate—Pruritus—Epirubicin—pancreatic cancer	0.000149	0.00114	CcSEcCtD
Magnesium salicylate—Diarrhoea—Epirubicin—pancreatic cancer	0.000144	0.0011	CcSEcCtD
Magnesium salicylate—Dizziness—Epirubicin—pancreatic cancer	0.000139	0.00106	CcSEcCtD
Magnesium salicylate—Pruritus—Doxorubicin—pancreatic cancer	0.000138	0.00105	CcSEcCtD
Magnesium salicylate—Vomiting—Epirubicin—pancreatic cancer	0.000134	0.00102	CcSEcCtD
Magnesium salicylate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000133	0.00102	CcSEcCtD
Magnesium salicylate—Rash—Epirubicin—pancreatic cancer	0.000132	0.00101	CcSEcCtD
Magnesium salicylate—Dermatitis—Epirubicin—pancreatic cancer	0.000132	0.00101	CcSEcCtD
Magnesium salicylate—Headache—Epirubicin—pancreatic cancer	0.000132	0.00101	CcSEcCtD
Magnesium salicylate—Dizziness—Doxorubicin—pancreatic cancer	0.000129	0.000984	CcSEcCtD
Magnesium salicylate—Nausea—Epirubicin—pancreatic cancer	0.000125	0.000955	CcSEcCtD
Magnesium salicylate—Vomiting—Doxorubicin—pancreatic cancer	0.000124	0.000946	CcSEcCtD
Magnesium salicylate—Rash—Doxorubicin—pancreatic cancer	0.000123	0.000938	CcSEcCtD
Magnesium salicylate—Dermatitis—Doxorubicin—pancreatic cancer	0.000122	0.000937	CcSEcCtD
Magnesium salicylate—Headache—Doxorubicin—pancreatic cancer	0.000122	0.000932	CcSEcCtD
Magnesium salicylate—Nausea—Doxorubicin—pancreatic cancer	0.000115	0.000884	CcSEcCtD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—pancreatic cancer	1.34e-05	0.0202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatic cancer	1.33e-05	0.0201	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—PIK3CD—pancreatic cancer	1.25e-05	0.0189	CbGpPWpGaD
Magnesium salicylate—PTGS2—S1P1 pathway—KDR—pancreatic cancer	1.23e-05	0.0186	CbGpPWpGaD
Magnesium salicylate—ALB—HDL-mediated lipid transport—APOE—pancreatic cancer	1.23e-05	0.0185	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—PTGS2—pancreatic cancer	1.08e-05	0.0163	CbGpPWpGaD
Magnesium salicylate—ALB—FOXA2 and FOXA3 transcription factor networks—SLC2A2—pancreatic cancer	1.06e-05	0.016	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—CXCL8—pancreatic cancer	1.05e-05	0.0159	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—PIK3CD—pancreatic cancer	9.96e-06	0.015	CbGpPWpGaD
Magnesium salicylate—PTGS1—Eicosanoid Synthesis—PTGS2—pancreatic cancer	8.99e-06	0.0136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	8.49e-06	0.0128	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—CXCL8—pancreatic cancer	8.34e-06	0.0126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—pancreatic cancer	7.78e-06	0.0117	CbGpPWpGaD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—pancreatic cancer	7.52e-06	0.0113	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—TNF—pancreatic cancer	7.32e-06	0.011	CbGpPWpGaD
Magnesium salicylate—ALB—Lipoprotein metabolism—APOE—pancreatic cancer	7.05e-06	0.0106	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	6.79e-06	0.0102	CbGpPWpGaD
Magnesium salicylate—PTGS2—S1P1 pathway—VEGFA—pancreatic cancer	6.78e-06	0.0102	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	6.17e-06	0.0093	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—TNF—pancreatic cancer	5.81e-06	0.00876	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—SOD2—pancreatic cancer	5.66e-06	0.00854	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—SOD2—pancreatic cancer	5.63e-06	0.00848	CbGpPWpGaD
Magnesium salicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—pancreatic cancer	5.49e-06	0.00828	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—RB1—pancreatic cancer	5.16e-06	0.00778	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—pancreatic cancer	5.04e-06	0.00761	CbGpPWpGaD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—PTGS2—pancreatic cancer	5e-06	0.00754	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—GADD45A—pancreatic cancer	4.86e-06	0.00733	CbGpPWpGaD
Magnesium salicylate—ALB—Lipid and lipoprotein metabolism—APOE—pancreatic cancer	4.68e-06	0.00706	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—HES1—pancreatic cancer	4.67e-06	0.00705	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—APOE—pancreatic cancer	4.61e-06	0.00695	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—SOD2—pancreatic cancer	4.58e-06	0.0069	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—SOD2—pancreatic cancer	4.49e-06	0.00678	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	4.35e-06	0.00656	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	4.23e-06	0.00638	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	3.9e-06	0.00588	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	3.85e-06	0.00581	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—pancreatic cancer	3.85e-06	0.0058	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—pancreatic cancer	3.68e-06	0.00555	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—SOD2—pancreatic cancer	3.64e-06	0.00548	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	3.45e-06	0.0052	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—SRC—pancreatic cancer	3.43e-06	0.00517	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	3.37e-06	0.00508	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—pancreatic cancer	3.34e-06	0.00504	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	3.31e-06	0.00499	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—pancreatic cancer	3.3e-06	0.00498	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—PTGS2—pancreatic cancer	3.18e-06	0.00479	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—pancreatic cancer	3.14e-06	0.00474	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—pancreatic cancer	3.07e-06	0.00464	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—pancreatic cancer	3.01e-06	0.00453	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—EGF—pancreatic cancer	2.87e-06	0.00433	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—pancreatic cancer	2.86e-06	0.00432	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—pancreatic cancer	2.84e-06	0.00428	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.83e-06	0.00427	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CDKN2A—pancreatic cancer	2.8e-06	0.00423	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	2.73e-06	0.00412	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—pancreatic cancer	2.68e-06	0.00404	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	2.57e-06	0.00387	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	2.56e-06	0.00386	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	2.48e-06	0.00374	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	2.44e-06	0.00367	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—RB1—pancreatic cancer	2.43e-06	0.00366	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	2.41e-06	0.00364	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CCND1—pancreatic cancer	2.37e-06	0.00357	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—TNF—pancreatic cancer	2.15e-06	0.00324	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	2.13e-06	0.00322	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA5—pancreatic cancer	2.06e-06	0.00311	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	2.04e-06	0.00308	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—NRAS—pancreatic cancer	2.04e-06	0.00307	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PPP2R5B—pancreatic cancer	1.95e-06	0.00294	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CXCL8—pancreatic cancer	1.94e-06	0.00292	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—MYC—pancreatic cancer	1.9e-06	0.00286	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CASP3—pancreatic cancer	1.85e-06	0.00279	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.85e-06	0.00278	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CCND1—pancreatic cancer	1.8e-06	0.00272	CbGpPWpGaD
Magnesium salicylate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	1.79e-06	0.00269	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.77e-06	0.00267	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—KRAS—pancreatic cancer	1.75e-06	0.00265	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP9—pancreatic cancer	1.75e-06	0.00264	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—VEGFA—pancreatic cancer	1.74e-06	0.00262	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TNF—pancreatic cancer	1.74e-06	0.00262	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TNF—pancreatic cancer	1.7e-06	0.00257	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PRSS1—pancreatic cancer	1.67e-06	0.00251	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	1.65e-06	0.00249	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—TGFB1—pancreatic cancer	1.59e-06	0.0024	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ZNRF3—pancreatic cancer	1.58e-06	0.00238	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PRSS1—pancreatic cancer	1.58e-06	0.00238	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TP53—pancreatic cancer	1.53e-06	0.00231	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	1.52e-06	0.00229	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	1.49e-06	0.00225	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	1.45e-06	0.00218	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ARG2—pancreatic cancer	1.45e-06	0.00218	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	1.44e-06	0.00218	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—DTX1—pancreatic cancer	1.43e-06	0.00215	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	1.42e-06	0.00213	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	1.38e-06	0.00208	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	1.35e-06	0.00203	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PRSS1—pancreatic cancer	1.32e-06	0.002	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.3e-06	0.00197	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	1.29e-06	0.00194	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	1.27e-06	0.00192	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TYMP—pancreatic cancer	1.26e-06	0.00191	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	1.26e-06	0.0019	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	1.23e-06	0.00185	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	1.22e-06	0.00183	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—DTX4—pancreatic cancer	1.2e-06	0.00181	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	1.19e-06	0.00179	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	1.18e-06	0.00179	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CD44—pancreatic cancer	1.17e-06	0.00176	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PPP2R5B—pancreatic cancer	1.16e-06	0.00176	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ARG2—pancreatic cancer	1.15e-06	0.00173	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	1.13e-06	0.00171	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA1—pancreatic cancer	1.13e-06	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HEY2—pancreatic cancer	1.12e-06	0.00169	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	1.1e-06	0.00166	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PRSS1—pancreatic cancer	1.07e-06	0.00161	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	1.07e-06	0.00161	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNA2—pancreatic cancer	1.05e-06	0.00159	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.04e-06	0.00157	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HEY1—pancreatic cancer	1.04e-06	0.00157	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GLP1R—pancreatic cancer	1.02e-06	0.00154	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TYMP—pancreatic cancer	1e-06	0.00151	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—DPYD—pancreatic cancer	1e-06	0.00151	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	9.87e-07	0.00149	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	9.84e-07	0.00148	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	9.82e-07	0.00148	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	9.63e-07	0.00145	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SLC2A2—pancreatic cancer	9.51e-07	0.00143	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.41e-07	0.00142	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ARG2—pancreatic cancer	9.28e-07	0.0014	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JAG2—pancreatic cancer	9.21e-07	0.00139	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	9.17e-07	0.00138	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	9.09e-07	0.00137	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.08e-07	0.00137	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MEN1—pancreatic cancer	9.08e-07	0.00137	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SLC2A2—pancreatic cancer	9.01e-07	0.00136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SHH—pancreatic cancer	8.66e-07	0.00131	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IAPP—pancreatic cancer	8.55e-07	0.00129	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	8.35e-07	0.00126	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.28e-07	0.00125	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.27e-07	0.00125	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HSPA1B—pancreatic cancer	8.21e-07	0.00124	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TYMP—pancreatic cancer	8.11e-07	0.00122	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GLP1R—pancreatic cancer	8.08e-07	0.00122	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	8.08e-07	0.00122	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—DPYD—pancreatic cancer	7.95e-07	0.0012	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	7.91e-07	0.00119	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	7.7e-07	0.00116	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SLC2A2—pancreatic cancer	7.55e-07	0.00114	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.47e-07	0.00113	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLAU—pancreatic cancer	7.46e-07	0.00112	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CD44—pancreatic cancer	7.36e-07	0.00111	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—JAG1—pancreatic cancer	7.35e-07	0.00111	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.21e-07	0.00109	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.21e-07	0.00109	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.14e-07	0.00108	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	7.07e-07	0.00107	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GCG—pancreatic cancer	7.06e-07	0.00106	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD44—pancreatic cancer	6.98e-07	0.00105	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HSPA1A—pancreatic cancer	6.93e-07	0.00104	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	6.83e-07	0.00103	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.7e-07	0.00101	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CG—pancreatic cancer	6.64e-07	0.001	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—STK11—pancreatic cancer	6.64e-07	0.001	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.57e-07	0.00099	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—EGF—pancreatic cancer	6.56e-07	0.000989	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GLP1R—pancreatic cancer	6.54e-07	0.000986	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—DPYD—pancreatic cancer	6.43e-07	0.00097	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.23e-07	0.000939	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SLC2A2—pancreatic cancer	6.11e-07	0.000921	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.04e-07	0.000911	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	6.01e-07	0.000907	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CD44—pancreatic cancer	5.84e-07	0.000881	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CD—pancreatic cancer	5.83e-07	0.00088	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.83e-07	0.000879	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.72e-07	0.000863	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TYMS—pancreatic cancer	5.71e-07	0.000861	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GCG—pancreatic cancer	5.6e-07	0.000845	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SMAD4—pancreatic cancer	5.51e-07	0.000831	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HES1—pancreatic cancer	5.38e-07	0.000811	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.31e-07	0.000801	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—STK11—pancreatic cancer	5.27e-07	0.000794	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CB—pancreatic cancer	5.09e-07	0.000767	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.95e-07	0.000746	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	4.91e-07	0.000741	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CD44—pancreatic cancer	4.73e-07	0.000713	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TERT—pancreatic cancer	4.71e-07	0.000711	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—APOE—pancreatic cancer	4.64e-07	0.0007	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.63e-07	0.000698	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.59e-07	0.000692	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GCG—pancreatic cancer	4.53e-07	0.000684	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TYMS—pancreatic cancer	4.53e-07	0.000683	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HIF1A—pancreatic cancer	4.51e-07	0.00068	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TSC2—pancreatic cancer	4.5e-07	0.000678	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APOE—pancreatic cancer	4.4e-07	0.000664	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.39e-07	0.000663	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—STK11—pancreatic cancer	4.26e-07	0.000643	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CG—pancreatic cancer	4.19e-07	0.000632	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SRC—pancreatic cancer	4.08e-07	0.000615	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NOTCH1—pancreatic cancer	4.06e-07	0.000612	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PPARG—pancreatic cancer	4.04e-07	0.00061	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4e-07	0.000603	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VEGFA—pancreatic cancer	3.97e-07	0.000599	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGF—pancreatic cancer	3.93e-07	0.000592	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—NRAS—pancreatic cancer	3.92e-07	0.000591	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—APOE—pancreatic cancer	3.69e-07	0.000556	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CD—pancreatic cancer	3.68e-07	0.000555	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TYMS—pancreatic cancer	3.67e-07	0.000553	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB1—pancreatic cancer	3.64e-07	0.000549	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CD—pancreatic cancer	3.49e-07	0.000527	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.49e-07	0.000526	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—KRAS—pancreatic cancer	3.37e-07	0.000509	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CG—pancreatic cancer	3.33e-07	0.000502	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CB—pancreatic cancer	3.21e-07	0.000484	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PPARG—pancreatic cancer	3.21e-07	0.000484	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTGS2—pancreatic cancer	3.18e-07	0.00048	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PIK3CA—pancreatic cancer	3.1e-07	0.000468	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CB—pancreatic cancer	3.04e-07	0.000459	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TP53—pancreatic cancer	3e-07	0.000452	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—APOE—pancreatic cancer	2.98e-07	0.00045	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CD—pancreatic cancer	2.92e-07	0.000441	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—HRAS—pancreatic cancer	2.87e-07	0.000433	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.82e-07	0.000426	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PTEN—pancreatic cancer	2.77e-07	0.000418	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CTNNB1—pancreatic cancer	2.7e-07	0.000407	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CG—pancreatic cancer	2.69e-07	0.000406	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PTEN—pancreatic cancer	2.63e-07	0.000397	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PPARG—pancreatic cancer	2.6e-07	0.000392	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CB—pancreatic cancer	2.55e-07	0.000384	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—AKT1—pancreatic cancer	2.53e-07	0.000382	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SRC—pancreatic cancer	2.44e-07	0.000368	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CD—pancreatic cancer	2.37e-07	0.000357	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT3—pancreatic cancer	2.35e-07	0.000355	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NRAS—pancreatic cancer	2.35e-07	0.000354	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PTEN—pancreatic cancer	2.2e-07	0.000332	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—pancreatic cancer	2.19e-07	0.00033	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFB1—pancreatic cancer	2.18e-07	0.000329	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—EGFR—pancreatic cancer	2.14e-07	0.000322	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CB—pancreatic cancer	2.06e-07	0.000311	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTGS2—pancreatic cancer	2.04e-07	0.000308	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KRAS—pancreatic cancer	2.02e-07	0.000305	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PIK3CA—pancreatic cancer	1.96e-07	0.000295	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PIK3CA—pancreatic cancer	1.86e-07	0.00028	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PTEN—pancreatic cancer	1.78e-07	0.000269	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HRAS—pancreatic cancer	1.72e-07	0.000259	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—AKT1—pancreatic cancer	1.6e-07	0.000241	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PIK3CA—pancreatic cancer	1.55e-07	0.000234	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—AKT1—pancreatic cancer	1.52e-07	0.000229	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—AKT1—pancreatic cancer	1.27e-07	0.000191	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PIK3CA—pancreatic cancer	1.26e-07	0.00019	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—AKT1—pancreatic cancer	1.03e-07	0.000155	CbGpPWpGaD
